CVE-2025-64489SuiteCRM: Privilege Escalation via Improper Session Invalidation and Inactive User Bypass
Updated under an hour ago ()
Does this affect you?
It affects SuiteCRM and 1 other product. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
SuiteCRM is an open-source, enterprise-ready Customer Relationship Management (CRM) software application. Versions 7.14.7 and prior, 8.0.0-beta.1 through 8.9.0 contain a privilege escalation vulnerability where user sessions are not invalidated upon account deactivation. An inactive user with an active session can continue to access the application and, critically, can self-reactivate their account. This undermines administrative controls and allows unauthorized persistence. This issue is fixed in versions 7.14.8 and 8.9.1.
- CVSS
- 8.3 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L
- Weakness (CWE)
- CWE-269
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- GitHub_M
- NVD analysis
- Analyzed
- Record last updated
- Nov 13, 2025
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
SuiteCRM SuiteCRM suitecrm:suitecrm (from the name) | before 7.14.8; from 8.0.0-beta.1, < 8.9.1 | CNA record |
salesagility suitecrm salesagility:suitecrm | before 7.14.8; from 8.0.0 before 8.9.1 | NVD |
References
- https://github.com/SuiteCRM/SuiteCRM/security/advisories/GHSA-j6jg-9jj3-q2phx-refsource-confirm, vendor-advisory
- https://github.com/SuiteCRM/SuiteCRM-Core/commit/30277cfe69755f7360a23d4805e06a5c38f14131x-refsource-misc, patch
- https://github.com/SuiteCRM/SuiteCRM/commit/40da2845a170832a4e9e9fa0ebe731f8c34de42dx-refsource-misc, patch
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.